Dashenlin Pharmaceutical Group Co Ltd (603233)

Shanghai
Currency in CNY
17.08
+0.26(+1.55%)
Closed·
603233 Scorecard
Full Analysis
Valuation implies a strong free cash flow yield
603233 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.7017.10
52 wk Range
11.9219.00
Key Statistics
Edit
Bid/Ask
17.04 / 17.05
Prev. Close
16.82
Open
16.73
Day's Range
16.7-17.1
52 wk Range
11.92-19
Volume
6.68M
Average Volume (3m)
7.39M
1-Year Change
18.34%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
603233 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
21.80
Upside
+27.63%
Members' Sentiments
Bearish
Bullish
ProTips
Pays a significant dividend to shareholders

Dashenlin Pharma Company Profile

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. It provides Chinese and western patent medicines, ginseng tonic medicinal materials and Chinese herbal pieces, health care products, medical equipment, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.

Employees
43532
Market
China

Compare 603233 to Peers and Sector

Metrics to compare
603233
Peers
Sector
Relationship
P/E Ratio
19.6x33.9x11.8x
PEG Ratio
−2.24−0.410.03
Price/Book
2.6x2.2x1.5x
Price / LTM Sales
0.7x0.7x0.9x
Upside (Analyst Target)
35.0%23.7%17.8%
Fair Value Upside
Unlock12.2%11.0%Unlock

Analyst Ratings

10 Buy
0 Hold
1 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 21.80
(+27.63% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.86%
Dividend Yield
3.63%
Industry Median 1.84%
Annualised payout
0.62
Paid annually
5-Years Growth
+16.47%
Growth Streak

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
0.40 / 0.3081
Revenue / Forecast
6.96B / 7.16B
EPS Revisions
Last 90 days

603233 Income Statement

FAQ

What Is the Dashenlin Pharma (603233) Stock Price Today?

The Dashenlin Pharma stock price today is 17.08.

What Stock Exchange Does Dashenlin Pharma Trade On?

Dashenlin Pharma is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Dashenlin Pharma?

The stock symbol for Dashenlin Pharma is "603233."

Does Dashenlin Pharma Pay Dividends? What’s The Current Dividend Yield?

The Dashenlin Pharma dividend yield is 3.63%.

What Is the Dashenlin Pharma Market Cap?

As of today, Dashenlin Pharma market cap is 19.44B.

What Is Dashenlin Pharma's Earnings Per Share (TTM)?

The Dashenlin Pharma EPS (TTM) is 0.86.

When Is the Next Dashenlin Pharma Earnings Date?

Dashenlin Pharma will release its next earnings report on 28 Aug 2025.

From a Technical Analysis Perspective, Is 603233 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Dashenlin Pharma Stock Split?

Dashenlin Pharma has split 5 times.

How Many Employees Does Dashenlin Pharma Have?

Dashenlin Pharma has 43532 employees.

What is the current trading status of Dashenlin Pharma (603233)?

As of 08 Jul 2025, Dashenlin Pharma (603233) is trading at a price of 17.08, with a previous close of 16.82. The stock has fluctuated within a day range of 16.70 to 17.10, while its 52-week range spans from 11.92 to 19.00.

What Is Dashenlin Pharma (603233) Price Target According to Analysts?

The average 12-month price target for Dashenlin Pharma is CNY21.8, with a high estimate of CNY25 and a low estimate of CNY12. 10 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +27.63% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.